G6PC1 and metabolic disease: Our results also shed new insight into the molecular genetics of GSD1a, as well as demonstrate the power of protein engineering by harnessing these learnings to enhance and optimize candidate mRNA-based therapies to treat GSD1a or other devastating inherited metabolic disorders with limited treatment or management options.